Regulatory 2021-01-14 | Information regarding transfer of shares in Ascelia Pharma AB from CMC SPV Download Presentation Webcast Excel
Regulatory 2021-01-12 | Ascelia Pharma presents clinical development plan for Oncoral as a novel chemotherapy Download Presentation Webcast Excel
Regulatory 2020-12-15 | Ascelia Pharma gets US patent for second generation Mangoral Download Presentation Webcast Excel
Regulatory 2020-12-02 | New study shows Mangoral’s lesion visualization as effective as gadolinium contrast agent Download Presentation Webcast Excel
Regulatory 2020-11-05 | Quarterly Report Q3-2020: Raised market estimate for Mangoral and preparing for market launch Download Presentation Webcast Excel
2020-11-03 | EMA confirms Mangoral eligible for the centralized regulatory procedure in the EU Download Presentation Webcast Excel
Regulatory 2020-10-21 | Upgraded estimate of addressable market for Mangoral to $500-600 million annually Download Presentation Webcast Excel
2020-09-30 | Invitation to Ascelia Pharma’s virtual Capital Markets Day Download Presentation Webcast Excel
Regulatory 2020-08-20 | Quarterly Report Q2-2020: First participant in the hepatic study Download Presentation Webcast Excel
